Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

1,702 public trials 178 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

A Safety and Efficacy Study of Eltrombopag in Subjects With AML

NCT01890746

Conditions: Acute Leukaemia, Blood Platelet Disorders, Cytopenia, +8 more
Locations: Novartis Investigative Site Farmington, Connecticut, United States

Novartis Investigative Site Miami, Florida, United States

Novartis Investigative Site Orlando, Florida, United States

Novartis Investigative Site Atlanta, Georgia, United States

View all 42 locations

View Trial Details

Completed

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

NCT00866749

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States

NCT00997386

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +27 more
Locations: University Medical Center and UMC-North Clinic Tucson, Arizona, United States

View Trial Details

Completed

A Phase I Study of NK Cell Infusion Following Allogeneic Peripheral Blood Stem Cell Transplantation From Related or Matched Unrelated Donors in Pediatric Patients With Solid Tumors and Leukemias

NCT01287104

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +26 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

NCT02272777

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +16 more
Locations: Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Guangzhou, Guangdong, China

Novartis Investigative Site Wuhan, Hubei, China

Novartis Investigative Site Nanjing, Jiangsu, China

View Trial Details

Completed

Trial of Sirolimus and Methotrexate in Relapsed/Refractory Lymphoblastic Leukemia and Lymphoma

NCT01162551

Conditions: Cancer, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell Transplantation

NCT00383994

Conditions: Chronic Disease, Disease Attributes, Disorder Related to Transplantation, +19 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers

NCT02409121

Conditions: Brain Diseases, Brain Neoplasms, Brain Tumor, +15 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands

NCT02891551

Conditions: Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations: Not specified

View Trial Details

Completed

LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE)

NCT02187783

Conditions: Adenoma, Adnexal Diseases, Breast Diseases, +31 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

Alaska Clinical Research Anchorage, Alaska, United States

Arizona Oncology Associates Dept. Of Onc. Phoenix, Arizona, United States

University of Arkansas/ Arkansas Cancer Research Center UA Medical Sciences Little Rock, Arkansas, United States

View all 61 locations

View Trial Details